• EMG

The Growing Market of Biotechnology

Biotechnology allows us to create, curate, and control pharmaceutical products. In this infographic, we consider the multi-functional use and potential of biotechnology, highlighting some of the biggest players in biotech, and forecasting how the market could ascend in the coming years.

6. Infographic.jpg
GOLD 14 Infographic.jpg

Over the past decade, innovative products have radically changed the landscape of the pharmaceutical industry. Our infographic highlights some of the biggest shifts, whilst showcasing future opportunities for innovation within the industry.

GOLD 12 Infographic.jpg
GOLD 11 Infographic.jpg

The global pharmaceutical industry employs > 4.4 million people, and this number is predicted to rise over the next decade. Our infographic showcases predictions for the 2030 UK biopharmaceutical workforce, highlighting where additional skills will be required to meet this increased demand.

Access to medicine around the world is still a huge challenge, most notably in developing countries. This infographic, the second in our ‘Improving Access’ series, pinpoints some standout examples of pharmaceutical companies who are going the extra mile to improve access for patients in Asia.

Improving Access Asia.jpg

As the industry commands the search for a COVID-19 vaccine, we reflect on the history of vaccine development. From the very first inoculation to the present day, this infographic celebrates the stories, companies, and notable individuals who have been pivotal in the development of vaccines. 

GOLD Infographic.jpg

As we process the huge impact the COVID-19 pandemic is having around the world, the pharmaceutical industry is hard at work to find a solution. This infographic tracks key milestones of the virus, vaccine and treatment efforts, and donations made by pharma to help the cause.

Pharmas Mission to Combat Coronavirus.jp

There are many notable initiatives put in place by pharma to improve access to medicine around the world, most notably in developing countries. This infographic pinpoints some standout examples of companies going the extra mile to improve access for patients in Africa.

GOLD 09 Infographic.jpg

The pharmaceutical industry is gradually populating the world of social media, as they find ways to navigate these platforms amidst the boundaries of compliance and regulation. This infographic examines which of the top pharma companies are performing best, analyses the language being used, and identifies key insights to bolster social profiles for the better.

Pharmas Social Media Report FA.jpg

Achieving gender parity in the pharmaceutical industry still has a way to go, but many companies are making significant strides towards this. Our infographic showcases a handful of standout examples from the industry and explores key milestones in the history of women in the workplace.

GOLD 08 FA 310.jpg

The drugs sales market is an ever-evolving landscape, especially today as the market fragments, and individualised therapies start to make their mark. In this infographic, we showcase how these trends are forecast to impact drugs sales by the year 2024, emphasising key differences with the 2018 figures, as well as predicting which therapeutic areas are set to take home the biggest sales.

In the 110 years since Paul Ehrlich discovered the first modern antibiotic, a wealth of information on antimicrobial resistance has come to the forefront. Our infographic takes a look over the history of antibiotics and pharma’s role in its story.

18-19_110 Years of Antibiotics FA.jpg

Investigation into cell therapies is growing at an exponential rate across the pharma industry. In this infographic, we display the number and types of cell therapies currently in the R&D pipeline, with a particular analysis of CAR T

cell therapy.

06 Infographic.png

2018 was a banner year for novel drug approvals. In this infographic we display an overview of drugs approved by the FDA and EMA, with special recognition of the orphan drugs that were brought to market in 2018. 

GOLD 05 Infographic-01.png

On Thursday 23 June 2016, the people of the UK voted to leave the EU, by a winning margin of 3.8%. There began the UK’s long and eventful route to leave, scheduled for Friday 29 March.
In this immersive infographic we mark important milestones the UK life-sciences sector has seen in this near 3-year period, and the events unfolding for the UK’s journey out of the EU.


We review some of the top selling biologics still to come off patent in the EU and US, and their respective biosimilars in the pipeline.

GOLD 04.png

We reflect on pharma’s past year and some of the major events that took place.

03 Infographic.jpg

Uncover the top selling drugs from 2017 and be enlightened on which drugs are projected to be the highest sellers of 2024.


Find out about the top pharma M&A's over the last 7 years, and which countries are leading the way.

Issue 1_MA Infographic-01.png



To Be or
to Belong?
14. To-Be-or-To-Belong-F.jpg

As diversity and inclusion become an established focus within the HR function, pharma companies must pursue the overarching goal of ‘belonging’, fostering a positive culture for all in the workplace.


“Taking Ownership of our Words, Priorities, and Actions to Create a Culture of Belonging”
13. Taking-Ownership-of-our-Words.jpg

Gender disparities continue to exist in the pharmaceutical workforce. The HBA explore how we can keep advancing the number of women, and especially women of colour, into leadership positions.


8. Brexit-Revisited.jpg

Brexit may have taken a back seat to the pandemic, however behind the scenes, the UK and the EU have been working hard adjusting and adapting to mitigate disruption to pharmaceutical innovation.

Never miss an update, subscribe!